Global Locator
Genzyme Websites
Health Care Professionals
Company
Products
Research
Patients
Responsibility
Careers
News
About Genzyme
Company Leadership
Business Units
News
Press Contacts
Subscribe to News
Recognition and Awards
Working With Genzyme
Global Reach
Download Genzyme Materials
Today is September 25, 2024. All times in Eastern Daylight Time.
Genzyme Responds to Sanofi-Aventis Letter
11/08/2010 - 05:55 PM
Genzyme Details Financial Recovery and Other Factors Driving Company’s Value
10/22/2010 - 11:30 AM
Genzyme Announces Webcast of Analyst and Investor Event
10/21/2010 - 03:34 PM
Genzyme Announces Results of Phase 3 Trial of Clolar in Adult AML
10/20/2010 - 10:32 AM
Genzyme Reports Financial Results for the Third Quarter of 2010
10/20/2010 - 09:22 AM
Genzyme’s Alemtuzumab Shows Sustained Reduction in Relapses and Disability in Five-Year Review of MS Patients from Phase 2 Trial
10/14/2010 - 09:30 AM
Genzyme Announces Upcoming Analyst and Investor Events
10/13/2010 - 04:00 PM
Genzyme Board Unanimously Rejects Sanofi-Aventis Tender Offer
10/07/2010 - 04:43 PM
Genzyme Board Urges Shareholders to Take No Action On Sanofi-Aventis’ Unsolicited Tender Offer
10/04/2010 - 10:56 AM
Synvisc Approved in Japan, Key Market for Viscosupplementation Products
09/20/2010 - 09:15 AM
Genzyme Announces Agreement to Sell Genetic Testing Business to LabCorp
09/13/2010 - 06:00 AM
Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESC
09/01/2010 - 03:00 AM
Genzyme Confirms Receipt of Unsolicited Proposal
08/30/2010 - 07:37 AM
Two-Year Data from Phase 2 Trial of Genzyme’s Eliglustat Tartrate for Gaucher Disease To Be Published in the Journal Blood
08/23/2010 - 09:15 AM
Genzyme and Isis Report Results of Two Phase 3 Trials of Mipomersen
08/04/2010 - 07:31 AM
Genzyme Encouraged by CMS Decision to Delay Oral Drug Inclusion in Dialysis Patient Benefit
07/27/2010 - 01:44 PM
Genzyme Reports Financial Results for the Second Quarter of 2010
07/21/2010 - 08:20 AM
Genzyme Announces Accelerated Share Repurchase
06/18/2010 - 08:50 AM
Shareholders Re-Elect All Members of Genzyme’s Board of Directors
06/16/2010 - 04:15 PM
Genzyme Prices Private Senior Notes Offerings
06/15/2010 - 08:50 AM
Genzyme’s Alemtuzumab for Treatment of Multiple Sclerosis Granted Fast Track Status by FDA
06/14/2010 - 02:48 PM
Genzyme and Carl Icahn Reach Agreement
06/09/2010 - 09:30 AM
Dennis Fenton Nominated for Election to Genzyme’s Board of Directors
06/07/2010 - 07:55 AM
Genzyme Receives FDA Approval for Lumizyme for Pompe Disease
05/25/2010 - 11:06 AM
Genzyme Announces Final Terms of FDA Consent Decree
05/24/2010 - 01:41 PM
1
2
3
4
5
6
7
8
9
10
11
12
« Previous
Next »
infoBox
LinkedIn
Yahoo! Buzz
Facebook
Twitter
Delicious
DIGG